Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW
However, due to discrepancies in findings from clinical trials, real-world data, and fundamental research, definitive recommendations for diabetic retinopathy screening prior to GLP-1 RA treatment initiation remain elusive
Common side effects include: Nausea Gas or bloating Heartburn Changes in bowel movements More serious risks, though uncommon, may include: Hypoglycemia (low blood sugar) Pancreatitis A slight increase in the risk of thyroid cancer Semaglutide Weight Loss Treatment At Northwest Face & Body, we offer both brand-name semaglutide (such as Wegovy or Ozempic) and compounded semaglutide with added customization
Active Ingredient Semaglutide: 0.68mg/ml solution (1mg per 1.5ml prefilled cartridge)
Yes, Hashimoto's disease itself is not a contraindication to GLP-1 use